Oriza-backed Chinese Biotechnology Firm Ascentage Pharma Files For Hong Kong IPO

Suzhou-based biopharmaceutical company Ascentage Pharma Group International has filed for an initial public offering in Hong Kong, according to its IPO prospectus.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

China Expert network

LEAVE A REPLY